Requery is an enterprise AI platform for biopharma teams who need to identify and evaluate external assets faster than any human team could manage alone. Describe what you're looking for in plain language and our agents will do the rest.
Trusted by BD, search & evaluation, and competitive intelligence teams.
Requery replaces a fragmented stack of databases, alerts, and spreadsheets with a single agentic platform purpose-built for asset intelligence in biopharma.
Describe your Query in plain language. Agents fan out across millions of primary sources - ClinicalTrials.gov, EU CTR, USPTO, EPO, PubMed, preprints, conference abstracts, SEC filings, and licensed datasets - and surface every asset that fits.
Every asset is scored against the criteria you defined - mechanism fit, clinical stage, whitespace, competitive density, geographic rights, and more - with the underlying evidence one click away.
Your shortlist is never stale. Requery re-ranks continuously as new trials post, patents publish, deals close, or papers preprint and tells you exactly what changed and why your ranking moved.
One paragraph in plain language. No Boolean queries, no controlled vocabularies - just describe what you'd brief an analyst with.
Pick the dimensions that matter for this thesis - and weight them or let us decide from comparable past landscapes.
Specialised agents query trial registries, IP offices, literature, and filings in parallel. Results are de-duplicated, normalised, and scored.
Every score links to its source. Drill from a number on a row to the exact clinical trial arm or patent claim that produced it.
Requery runs forever. You'll know within minutes when a new asset appears or a ranked one changes, with a one-line explanation of why.
Requery reads the underlying records directly. Every score traces back to a citable primary source: a trial protocol, a patent claim, a filing footnote, a paper paragraph.
From two weeks to one afternoon - smarter search, stronger insights, no missed opportunities. With Requery, generate a defensible, fully cited shortlist.
See Requery perform against a real landscape from your pipeline.
For BD, search & evaluation, competitive intelligence, and portfolio strategy teams.
